- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03050320
Improving Resilience and Longevity for Workers Through Exercise
16 de novembro de 2017 atualizado por: McMaster University
The purpose of this study is to examine the impact of an OA-specific aerobic and strengthening exercise program, delivered within the workplace, on mobility, pain, physical capacity, and resilience among workers with knee or hip OA as well as those with no joint pain.
The investigators hypothesize that exercise designed for OA, delivered at work, will improve all of these outcomes.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
The Canadian workforce is aging.
The most prevalent age group is 50-54 years and most of these Canadians will aim to continue working over the next 10 years.
However, the impact of arthritis on aging Canadians compromises their ability to continue working.
By 2031, over 2 million Canadians aged 45 to 64 years will have arthritis.
The investigators aim to boost the ability of adults with the most common arthritis, osteoarthritis (OA), as well as adults without OA, to engage in the workforce for as long as they desire.
Identifying strategies to promote productivity among workers with knee and hip OA will be of great public health significance in the coming decades.
However, the investigators face two challenges.
First, obesity among sedentary workers is a risk for worsening knee and hip OA.
Second, large occupational loads on the knee and hip worsen OA.
Exercise has the most promise in addressing these challenges because it reduces pain and sick time, and improves mental health.
Thus, there is a call for studies examining exercise for workers with knee and hip OA.
Tipo de estudo
Intervencional
Inscrição (Real)
43
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Ontario
-
Hamilton, Ontario, Canadá, L8S4L8
- McMaster University
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- full-time or part-time administrative employees
Exclusion Criteria:
- Any other forms of arthritis
- Osteoporosis-related fracture
- History of patellofemoral symptoms
- Active non-arthritic hip or knee disease
- Hip or knee surgery
- Use of cane or walking aid
- Unstable heart condition
- Neurological conditions
- Hip, knee or ankle injuries in past 3 months
- Physician-advised restriction to physical activity
- Any injuries that would prohibit participation in exercise
- Ipsilateral ankle conditions
- Currently receiving cancer treatment
- Currently pregnant
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: Exercise
The participants in this arm will be asked to attend 3 group classes per week for 12 weeks taught by a certified exercise instructor.
Five class times will be offered per week.
These classes included a warm-up, static poses shown to decrease knee joint loading, and a cool down including flexibility exercises.
Measurements will be obtained at baseline (before intervention) and at follow-up (following intervention).
Outcomes included clinical mobility; pain; isometric leg strength; cardiovascular fitness; and resilience.
|
A biomechanical exercise program shown to decrease joint loading will be administered 3 times a week for 12 weeks.
Outcomes included mobility performance; pain; strength; cardiovascular fitness; and resilience.
|
Outro: No Exercise
The participants in this arm will be asked to refrain from changing their physical activity over the 12 weeks and maintain any strategies typically used to manage knee and/or hip pain.
Since it is known that exercise is beneficial for pain management and strengthening in knee OA, participants randomized to the no exercise group will be offered the same exercise program following completion of the study.
Measurements will be obtained at baseline (before intervention) and at follow-up (following intervention).
Outcomes included clinical mobility; pain; isometric leg strength; cardiovascular fitness; and resilience.
|
A no exercise (control) group will be asked to maintain their existing activity level for 12 weeks.
Outcomes included mobility performance; pain; strength; cardiovascular fitness; and resilience.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Change in Lower Extremity Functional Scale
Prazo: Weeks 1 and 13
|
The Lower Extremity Function Scale (LEFS) consists of 20 items, on an adjectival scale, that assess difficulty during mobility tasks ranging from transfers to running.
Each item is scored from 0 (extreme difficulty or unable to perform activity), to 4 (no difficulty to perform activity).
The minimum possible score is 0, and the maximum possible score is 80. Scores closer to 80 represent better self-reported physical function.
It is reliable and valid in knee OA and has superior sensitivity to change compared to similar measures
|
Weeks 1 and 13
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Change in Self-reported Knee and Hip Pain
Prazo: Weeks 1 and 13
|
Change in self-reported knee and hip pain will be assessed with 3 valid and reliable questionnaires: the Knee injury and Osteoarthritis Outcome Score (KOOS), the Hip disability and Osteoarthritis Outcome Score (HOOS), and the Intermittent and Constant Osteoarthritis Pain (ICOAP) score.
The KOOS and HOOS pain scores represent a normalized score from 0 (extreme symptoms) to 100 (no symptoms).
KOOS and HOOS scores closer to 100 indicate fewer symptoms.
The ICOAP consists of two sub-scales: constant pain (5 items) and intermittent pain (6 items).
The score from each subscale represents a normalized score from 0 (no pain) to 100 (extreme pain).
ICOAP scores closer to 0 indicate less pain.
The items from each subscale are averaged to produce a normalized ICOAP total score, ranging from 0 (no pain) to 100 (extreme pain).
|
Weeks 1 and 13
|
Change in Self-reported Upper Extremity Pain
Prazo: Weeks 1 and 13
|
The Disabilities of the Arm Shoulder and Hand is a 30-item questionnaire addressing upper extremity physical function and symptoms.
The DASH is suitable for people with any upper limb musculoskeletal disorders and can also monitor changes in severity of symptoms and functional abilities over time.
Each item is scored from 1 (no difficulty) to 5 (unable).
Total scores range from 0 to 100, with higher scores indicating more upper limb problems.
|
Weeks 1 and 13
|
Change in Isometric Knee Extensor and Flexor Strength
Prazo: Weeks 1 and 13
|
The peak torque developed during knee extension and flexion during a maximum isometric contraction will be measured by use of a ergoFET hand-held dynamometer.
|
Weeks 1 and 13
|
Change in Grip Strength
Prazo: Weeks 1 and 13
|
Grip strength will be assessed using a Jamar hand dynamometer.
The hand dynamometer will be set to a fixed position and all values of grip force will be expressed in kg.
|
Weeks 1 and 13
|
Change in Cardiovascular Fitness
Prazo: Weeks 1 and 13
|
Cardiovascular fitness will be calculated using the Single Stage Treadmill Walking Test.
Predictions of VO2max will be made from heart rate (measured with a heart rate monitor), walking speed, age and gender.
|
Weeks 1 and 13
|
Change in Mobility Performance (Six-Minute Walk Test)
Prazo: Weeks 1 and 13
|
Mobility performance will be measured using the Six-Minute Walk Test (6MWT).
For this test, participants are instructed to walk as far as possible in 6 minutes.
The distance covered in 6 minutes is recorded in metres.
This measure has produced reliable and valid data in persons with knee OA.
|
Weeks 1 and 13
|
Change in Mobility Performance (Stair Ascent and Descent)
Prazo: Weeks 1 and 13
|
Mobility performance will be measured using the Stair Ascent and Descent Test.
For this test, the time taken to ascend, as well as descend nine stairs is recorded in seconds.
This measure has produced reliable and valid data in persons with knee OA.
|
Weeks 1 and 13
|
Change in Mobility Performance (30-second Chair Stand Test)
Prazo: Weeks 1 and 13
|
Mobility performance will be measured using the 30-second Chair Stand Test.
This test measures the number of times participants can rise and lower from a standard height chair, without using arm rests, in a 30-second period.This measure has produced reliable and valid data in persons with knee OA.
|
Weeks 1 and 13
|
Change in Resilience
Prazo: Weeks 1 and 13
|
Resilience will be measured using the Resilience Scale 25 Survey, which is a 25-item questionnaire designed to evaluate a participants ability to adapt to stress and adversity.
The test is scored out of 175 (scores ranging from 25 to 175), with higher scores indicating higher resilience.
|
Weeks 1 and 13
|
Change in Work Ability
Prazo: Weeks 1 and 13
|
The Work Ability Index (WAI) is a widely-used self-report questionnaire that evaluates a worker's capacity to perform a job accounting for their physical and mental well-being in addition to the demands of their job.
The WAI consists of seven dimensions including current work ability relative to life-time best, work ability related to job demands, number of current physician-diagnosed health conditions, estimated work impairment due to the conditions, sick leave over the past year, own prognosis, and mental resources.
Total scores range from 7 to 49 and can fall under one of four classifications: poor work ability that should be restored (7-27), moderate work ability that should be improved (28-36), good work ability that should be supported (37-43), and excellent work ability that should be maintained (44-49).
The WAI produces reliable data.
|
Weeks 1 and 13
|
Change in Depressive Symptoms
Prazo: Weeks 1 and 13
|
Depression will be assessed with the Centre of Epidemiological Studies Depression (CES-D) Scale, a 20-item scale developed for the general population with emphasis on affect.
Elements of affect include mood, guilt, worthlessness, helplessness, appetite, and sleep.
Each item is scored from 0 (rarely or none of the time), to 3 (most of the time).
The items are summed to produce a total score between 0 and 60 with a score of 16 or higher indicating depression.
|
Weeks 1 and 13
|
Change in Arthritis-related Self-Efficacy
Prazo: Weeks 1 and 13
|
The Arthritis Self-Efficacy Scale (ASES) measures arthritis-specific beliefs regarding perception of performance on certain tasks to cope with the disease.
The ASES is measured using 20 questions on a 10-100 scale with respect to three main areas: pain management (5 questions), physical function (9 questions), and other symptoms (6 questions).
Each question is scored from 10 (very uncertain), to 100 (very certain), in 10-point increments.
The minimum score for each subscale is 10, and the maximum score for each subscale is 100.
The scores from each subscale are averaged to produce a normalized total score.
Scores closer to 100 indicate greater certainty that a participant can cope with a particular task as a consequence of their disease.
|
Weeks 1 and 13
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Monica R Maly, PT, PhD, McMaster University
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
8 de fevereiro de 2017
Conclusão Primária (Real)
30 de junho de 2017
Conclusão do estudo (Real)
30 de junho de 2017
Datas de inscrição no estudo
Enviado pela primeira vez
8 de fevereiro de 2017
Enviado pela primeira vez que atendeu aos critérios de CQ
8 de fevereiro de 2017
Primeira postagem (Real)
10 de fevereiro de 2017
Atualizações de registro de estudo
Última Atualização Postada (Real)
10 de agosto de 2018
Última atualização enviada que atendeu aos critérios de controle de qualidade
16 de novembro de 2017
Última verificação
1 de novembro de 2017
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Workplace Exercise
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Não
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .